Aetna modified CPB 0514 covering Meniere's disease surgery, effective January 5, 2026. Here's what billing teams need to know about covered procedures, excluded codes, and claim denial risks.
Aetna, a CVS Health company, updated its Meniere's disease surgery coverage policy under CPB 0514 Aetna system. This policy governs surgical treatment for chronic refractory Meniere's disease, superior semicircular canal dehiscence, and sudden sensorineural hearing loss. The update clarifies which procedures Aetna considers medically necessary—and which it now explicitly calls experimental—affecting CPT codes 69801, 69805, 69806, 69905, 69910, 69915, 69950, and several others across otolaryngology and neurotology billing.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Meniere's Disease Surgery — CPB 0514 |
| Policy Code | CPB 0514 |
| Change Type | Modified |
| Effective Date | January 5, 2026 |
| Impact Level | High |
| Specialties Affected | Otolaryngology, Neurotology, Audiology, Neurosurgery |
| Key Action | Audit your charge capture for excluded procedures—especially simultaneous labyrinthectomy with cochlear implantation and tenotomy—before submitting claims against this updated policy |
Aetna Meniere's Disease Surgery Coverage Criteria and Medical Necessity Requirements 2026
The Aetna Meniere's disease surgery coverage policy divides covered procedures into two tracks: surgical procedures non-destructive to hearing, and surgical procedures destructive to hearing. Both tracks require a diagnosis of chronic refractory Meniere's disease and meet specific selection criteria outlined in the policy appendix.
Medical necessity for hearing-preserving procedures includes:
| # | Covered Indication |
|---|---|
| 1 | Endolymphatic mastoid shunt (CPT 69806) |
| 2 | Endolymphatic sac decompression or drainage (CPT 69805) |
| 3 | Intra-tympanic corticosteroid injections/perfusions (no specific CPT code is identified in CPB 0514 for this procedure — verify the appropriate code with your coding resources or Aetna directly) |
| 4 | Lateral semicircular canal plugging |
| 5 | Perilymphatic fistula patching |
| 6 | Sacculotomy |
| 7 | Tympanostomy tube insertion (CPT 69433, 69436) |
| 8 | Vestibular nerve decompression (CPT 64716) |
| 9 | Vestibular neurectomy or neurotomy, including middle fossa or retrosigmoid approaches (CPT 61590, 61591, 61592, 69950) |
For procedures destructive to hearing, medical necessity applies to:
| # | Covered Indication |
|---|---|
| 1 | Cochleosacculotomy |
| 2 | Intra-tympanic gentamicin (CPT 69801) |
| 3 | Labyrinthectomy (CPT 69905, 69910) |
| 4 | Translabyrinthine vestibular neurectomy (CPT 69915) |
| 5 | Vestibulocochlear neurectomy |
One critical carve-out: for bilateral Meniere's disease, ablative treatments are relatively contraindicated. The risk of bilateral vestibular and cochlear hypofunction makes these procedures a harder medical necessity argument with Aetna. If your patient has bilateral disease and your team is billing CPT 69905 or 69910, document that contraindication discussion thoroughly.
Aetna also covers two additional indications under this updated coverage policy.
For superior semicircular canal dehiscence, Aetna covers middle fossa craniotomy (CPT 61590, 61591, 61592) and trans-mastoid canal plugging—but only when the diagnosis is confirmed by both audiometry and computed tomography. The ICD-10 codes that apply here are H83.8x1 through H83.8x9. Both diagnostic tests in the chart before you submit.
For sudden sensorineural hearing loss (ICD-10 H90.3–H90.A32), Aetna covers intra-tympanic or trans-tympanic dexamethasone injection when the member has failed conservative treatment including oral steroids, or when oral steroids are medically contraindicated. CPB 0514 does not identify a specific CPT code for this indication in the covered codes table. Verify the appropriate billing code with your coding resources or Aetna directly before submitting claims for this service. This is a step-therapy requirement. Document the failed oral steroid trial or the contraindication clearly in the record.
This policy does not specify prior authorization requirements in the summary text. That said, given the surgical complexity and the number of codes involved, verify prior authorization requirements for each procedure at the plan level before scheduling. Reimbursement claims without appropriate pre-service review are the fastest path to a claim denial on these codes.
Aetna Meniere's Disease Surgery Exclusions and Non-Covered Indications
Six procedures are explicitly experimental, investigational, or unproven under CPB 0514. Aetna will not cover these for chronic refractory Meniere's disease, regardless of diagnosis codes or documentation.
The excluded procedures are:
| # | Excluded Procedure |
|---|---|
| 1 | Cochleostomy with neurovascular transplant — no established effectiveness |
| 2 | Intra-tympanic injection of dexamethasone thermo-sensitive gel — distinct from standard dexamethasone injection; the gel formulation specifically is excluded |
| 3 | Positive pressure therapy for improving outcomes of endolymphatic sac surgery — also governed by CPB 0238 (Chronic Vertigo); HCPCS E2120 covers the pulse generator system for tympanic treatment and is not covered |
| 4 | Simultaneous labyrinthectomy with cochlear implantation for bilateral Meniere's disease — CPT 69930 and HCPCS L8614–L8629 are not covered for this indication |
| 5 | Tenotomy of the stapedius and tensor tympani muscles — no coverage |
| 6 | Triple semicircular canal plugging — no coverage |
The simultaneous labyrinthectomy/cochlear implantation exclusion deserves a flag for your billing team. Cochlear implant coding is high-dollar—CPT 69930, plus diagnostic codes 92601–92604, plus device codes L8614 through L8629. If a surgeon performs labyrinthectomy (CPT 69905 or 69910) and cochlear implantation in the same operative session for a bilateral Meniere's patient, the cochlear implant component will be denied. The policy notes CPT 69905 and 69910 individually as covered but explicitly states they are "not covered with simultaneous cochlear implantation."
This is a real claim denial risk. Pull your surgical cases involving bilateral Meniere's disease and make sure no one is bundling these procedures under one authorization.
The dexamethasone thermo-sensitive gel exclusion is also worth a second look. Standard intra-tympanic dexamethasone injection for sudden sensorineural hearing loss is covered. The gel formulation is not. If your providers use a branded or compounded slow-release gel preparation, that distinction matters at claims adjudication.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Chronic refractory Meniere's disease — hearing-preserving procedures | Covered | CPT 69433, 69436, 69805, 69806, 64716, 69950, 61590, 61591, 61592 | Selection criteria in policy appendix required; no specific CPT code listed in CPB 0514 for intra-tympanic corticosteroid injections — verify with coding resources or Aetna |
| Chronic refractory Meniere's disease — hearing-destructive procedures | Covered | CPT 69801, 69905, 69910, 69915 | Relatively contraindicated for bilateral disease; ablative risks must be documented |
| Superior semicircular canal dehiscence | Covered | CPT 61590, 61591, 61592; ICD-10 H83.8x1–H83.8x9 | Requires audiometry AND CT confirmation |
| Sudden sensorineural hearing loss — intra-tympanic dexamethasone | Covered | ICD-10 H90.3–H90.A32; no specific CPT code identified in CPB 0514 — verify with coding resources or Aetna | Requires failed oral steroids or medical contraindication to oral steroids |
| Cochleostomy with neurovascular transplant | Experimental | N/A | Not covered — effectiveness not established |
| Intra-tympanic dexamethasone thermo-sensitive gel | Experimental | N/A | Distinct from standard dexamethasone injection; excluded |
| Positive pressure therapy for endolymphatic sac surgery outcomes | Experimental | HCPCS E2120 | Not covered; see also CPB 0238 |
| Simultaneous labyrinthectomy with cochlear implantation (bilateral Meniere's) | Not Covered | CPT 69930, 92601–92604; HCPCS L8614–L8629 | Cochlear implant component denied when billed with labyrinthectomy for this indication |
| Tenotomy of stapedius and tensor tympani muscles | Experimental | N/A | Not covered |
| Triple semicircular canal plugging | Experimental | N/A | Not covered |
Aetna Meniere's Disease Surgery Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Audit all bilateral Meniere's disease cases for simultaneous cochlear implant billing. Pull claims from the past 12 months where CPT 69905 or 69910 appears alongside CPT 69930 or HCPCS L8614–L8629. If those were billed together for bilateral Meniere's, you have potential overpayment exposure. Correct those proactively before Aetna flags them. |
| 2 | Separate dexamethasone formulations in your charge capture. Standard intra-tympanic dexamethasone injection for sudden sensorineural hearing loss is covered. The thermo-sensitive gel formulation is not. Work with your pharmacy and surgical staff to document which formulation was used, and make sure that distinction is visible in the operative note and the claim. |
| 3 | Confirm dual diagnostic workup before billing for superior semicircular canal dehiscence. CPT codes 61590, 61591, and 61592 for middle fossa craniotomy require both audiometry and CT confirmation of the diagnosis. Check that both tests are in the chart and referenced in the procedure note before the effective date of any claim submission. Missing one of those two diagnostic legs is a direct path to a claim denial. |
| 4 | Document failed oral steroid therapy for sudden sensorineural hearing loss claims. Aetna covers intra-tympanic dexamethasone injection for sudden sensorineural hearing loss when the member has failed oral steroids or has a documented contraindication to them. CPB 0514 does not identify a specific CPT code for this indication in the covered codes table — verify the correct billing code with your coding resources or Aetna before submitting claims. Regardless of which code you use, the chart must show either a documented trial of oral steroids that failed or a clear contraindication. Aetna's step-therapy requirement here is explicit. No documentation, no reimbursement. |
| 5 | Verify selection criteria documentation matches the policy appendix. Every covered procedure under CPB 0514 is contingent on meeting the chronic refractory Meniere's disease selection criteria listed in the policy appendix. Pull that appendix and compare it against your intake and documentation templates. If your templates don't capture the specific criteria Aetna uses, update them now—before January 5, 2026 claims hit adjudication. |
| 6 | Check plan-level prior authorization requirements for high-dollar procedures. CPT 69905, 69910, 69915, and the cranial approach codes (61590, 61591, 61592) carry significant reimbursement value. Call the plan or check the portal for each patient's specific benefit design. Prior authorization rules vary by plan even within Aetna's network. Don't assume the policy-level coverage determination answers the prior auth question. |
If you have a high volume of bilateral Meniere's disease cases or a neurotology practice that performs labyrinthectomy with cochlear implantation, loop in your compliance officer before the effective date of January 5, 2026. The exclusion on simultaneous procedures creates real financial exposure if those claims were approved under a prior policy version.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Meniere's Disease Surgery Under CPB 0514
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 61590 | CPT | Infratemporal pre-auricular approach to middle cranial fossa (parapharyngeal space, infratemporal and middle cranial fossa) |
| 61591 | CPT | Infratemporal post-auricular approach to middle cranial fossa (internal auditory meatus, petrous apex) |
| 61592 | CPT | Orbitocranial zygomatic approach to middle cranial fossa (cavernous sinus and carotid artery, clivus) |
| 64716 | CPT | Neuroplasty and/or transposition; cranial nerve (vestibular — non-destructive to hearing) |
| 69433 | CPT | Tympanostomy (requiring insertion of ventilating tube), local or topical anesthesia |
| 69436 | CPT | Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
| 69676 | CPT | Tympanic neurectomy |
| 69801 | CPT | Labyrinthotomy, with perfusion of vestibuloactive drug(s); transcanal (intra-tympanic gentamicin) |
| 69805 | CPT | Endolymphatic sac operation; without shunt |
| 69806 | CPT | Endolymphatic sac operation; with shunt |
| 69905 | CPT | Labyrinthectomy; transcranial (not covered with simultaneous cochlear implantation) |
| 69910 | CPT | Labyrinthectomy; with mastoidectomy (not covered with simultaneous cochlear implantation) |
| 69915 | CPT | Vestibular nerve section, translabyrinthine approach |
| 69950 | CPT | Vestibular nerve section, transcranial approach |
Not Covered / Experimental Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| 69930 | CPT | Cochlear device implantation, with or without mastoidectomy | Not covered for indications listed in CPB 0514 (simultaneous with labyrinthectomy for bilateral Meniere's) |
| 92601 | CPT | Diagnostic analysis of cochlear implant | Not covered for indications listed in CPB 0514 |
| 92602 | CPT | Diagnostic analysis of cochlear implant | Not covered for indications listed in CPB 0514 |
| 92603 | CPT | Diagnostic analysis of cochlear implant | Not covered for indications listed in CPB 0514 |
| 92604 | CPT | Diagnostic analysis of cochlear implant | Not covered for indications listed in CPB 0514 |
| E2120 | HCPCS | Pulse generator system for tympanic treatment of inner ear endolymphatic fluid | Not covered — positive pressure therapy is experimental under CPB 0514 |
| L8614 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8615 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8616 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8617 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8618 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8619 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8620 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8621 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8622 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8623 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8624 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8625 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8626 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8627 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8628 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
| L8629 | HCPCS | Cochlear implant and other components | Not covered for indications listed in CPB 0514 |
Key ICD-10-CM Diagnosis Codes
| Code | Description |
|---|---|
| H81.1–H81.9 | Meniere's disease (active) — covers unilateral, bilateral, and unspecified variants |
| H83.8x1–H83.8x9 | Other specified diseases of inner ear (superior semicircular canal dehiscence) |
| H90.3–H90.A32 | Conductive and sensorineural hearing loss (applicable to sudden sensorineural hearing loss indication) |
Get the Full Picture for CPT 69806
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.